Professor Bernd Möbius is a leading academic in Phonetics and Phonology at the Department of Language Science and Technology, Saarland University. His research bridges phonetic theory with speech technology applications, focusing on text-to-speech systems, prosody modeling, and computational simulations of speech processes. Current research projects: DFG SFB 1102, C1: Information density and phonetic structure predictability DFG SFB 1102, C4: Slavic intercomprehension and surprisal theory (INCOMSLAV) Research Themes: Key areas include text-to-speech synthesis, speech prosody analysis, experimental methods in speech production/perception, information density in phonetics, and cross-linguistic studies of Slavic-Germanic languages. Scientific Contributions: Recent work explores Parkinson-induced dysarthria detection, breath noise acoustics, surprisal-driven speech behaviors, multilingual BERT models for idiomaticity, and perceptual consequences of acoustic adjustments.
Prof. Dr. Nina Gantert is a distinguished Professor of Probability Theory at the Technical University of Munich (TUM) , affiliated with the TUM School of Computation, Information and Technology . She has held faculty positions at Karlsruhe Institute of Technology and the University of Münster prior to joining TUM in 2011. Her research focuses on probability theory , particularly stochastic processes , large deviations , and random media . She investigates random walks in random environments as models for transport in disordered systems and explores applications in physics and biology . Recent publications highlight her work on branching random walks , mixing times , biased random walks , and large deviation principles for complex stochastic systems. She has co-authored studies on random walks in dynamical percolation , interacting edge-reinforced processes , and extremal point processes in branching models. Scientific Awards: Elected fellow of the IMS (2016) Her academic career spans institutions including ETH Zürich, University of Bonn, Technical University of Berlin, and TUM. She has supervised numerous Bachelor’s and Master’s theses on topics ranging from mixing time analysis to percolation theory , often collaborating with international co-authors.
Prof. Dr. Frank Pollmann is a Full Professor (W3) at the Department of Physics PH-I, Technical University of Munich (TUM), leading the Chair of Theoretical Solid-State Physics since 2022. His research focuses on condensed matter theory and quantum information concepts , particularly in systems of correlated electrons and quantum many-body dynamics . PhD: Max Planck Institute for the Physics of Complex Systems / TU Ilmenau (2006) Postdoc: UC Berkeley (2008-2010) Group Leader: MPIPKS Dresden (2011-2016) Associate Professor: TUM (2017-2022) His work spans topological phases , frustrated spin systems , and non-equilibrium quantum dynamics , utilizing tensor network methods and quantum information theory to study phenomena like many-body localization and Hilbert space fragmentation . His publications demonstrate trends in quantum scar states , Kardar-Parisi-Zhang hydrodynamics , and quantum transport anomalies . Scientific Awards : ERC Consolidator Grant (2017) Walter Schottky Prize (2015) Otto-Hahn Medal (2007) He teaches courses including Advanced Methods in Quantum Many-Body Theory , Solid State Theory , and Topology in Condensed Matter , while leading the Pollmann Group under the TUM School of Natural Sciences.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Dr. Sabine Krabbe is a Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany, where she leads research on neural circuit mechanisms underlying adaptive learning and state-dependent decision-making. Her work integrates neuroscience, molecular biology, and behavioral approaches to understand how internal states influence behavior and how these processes are disrupted in neurological disorders. Dr. Krabbe's research focuses on the interactions between midbrain circuits of the substantia nigra and ventral tegmental area with their output structures such as the striatum and amygdala. She investigates how these networks integrate internal states with environmental cues to produce appropriate behavioral responses. Her laboratory employs state-of-the-art techniques including deep-brain calcium imaging at single-cell resolution in mice, opto- and pharmacogenetic manipulations, anatomical tracings, and molecular approaches to characterize neural circuit elements in detail. Her recent publications reveal significant insights into amygdala interneuron plasticity during fear learning, brain-wide representational drift in memory consolidation, and the molecular mechanisms underlying Parkinson's disease progression. Her work demonstrates how activity patterns within specific neural circuits change in early stages of neurodegenerative diseases and how this dysfunction contributes to cognitive deficits and emotional disturbances. Dr. Krabbe is actively involved in the neuroscience community, organizing the BonnBrain Conference 2026 and sharing research through social media platforms. She has established herself as an emerging leader in the field of systems neuroscience with a particular focus on the neural basis of emotional states and decision-making processes.
Shrikanth (Shri) Narayanan is University Professor and Niki & C. L. Max Nikias Chair in Engineering at the University of Southern California (USC), with appointments spanning Electrical & Computer Engineering, Computer Science, Linguistics, Psychology, Neuroscience, Pediatrics, and Otolaryngology-Head & Neck Surgery. He serves as Research Director of the Information Sciences Institute and Director of the Ming Hsieh Institute. PhD in Electrical Engineering (UCLA, 1995) Engineer and MS in Electrical Engineering (UCLA, 1992 and 1990) BE in Electrical Engineering (Anna University, India, 1988) His interdisciplinary research focuses on human-centered signal processing and machine intelligence , addressing societal challenges in health, education, defense, and media arts. Key areas include: Behavioral signal processing Affective computing Multimodal signal processing Computational speech science Biomedical applications Scientific Awards : IEEE James L. Flanagan Speech and Audio Processing Award (2025) Edward J. McCluskey Technical Achievement Award (2024) ISCA Medal for Scientific Achievement (2023) Claude Shannon-Harry Nyquist Technical Achievement Award (2023) ACM ICMI Sustained Accomplishment Award (2020) USC Distinguished Faculty Service Award With over 1,000 publications and 19 patents , his work has been commercialized through startups like Behavioral Signals Technologies and Lyssn . He leads transformative university initiatives and has served in editorial roles for top journals including Computer Speech and Language and IEEE Transactions on Affective Computing .
Marc Erich Latoschik is a Professor in the Department of Human-Computer Interaction at the University of Würzburg, Germany. He previously held roles at Bayreuth University, Bielefeld University, and FHTW Berlin. His research focuses on virtual and augmented reality, embodiment, human-computer interaction, and applications in health, education, and social systems. Education: Completed his PhD in 2001 at Bielefeld University with a thesis on multimodal interaction in virtual reality. Research Interests: Embodied interaction, virtual embodiment, presence and plausibility in VR/AR, avatar design, social virtual reality, health applications (e.g., VR therapy for body image issues), and XR security/privacy. Active in developing frameworks like Reality Stack I/O and MAIL for VR/AR research. Key Projects: ViTraS study on body image exercises in VR, avatars for mass use via smartphone reconstruction, and motion-based biometrics in XR. Collaborates with medical teams on cybersickness detection and emergency training simulations. Labs/Teams: Leads research groups on immersive technologies and social VR applications. Involved in interdisciplinary projects combining HCI, AI, and healthcare.
Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .
Prof. Dr. Simon Schäfer leads the Schäfer Lab at the Technische Universität München , focusing on engineering advanced organoid systems to study human brain development, disease modeling, and repair mechanisms. His work bridges stem cell biology, gene editing, and bioengineering to develop personalized therapies for brain disorders. Stem Cell & Organoid Technology Neurodevelopmental Mechanisms Neurodegenerative Disease Models Gene Editing & Neuroimmune Interactions Translational Neuroscience Recent research emphasizes brain organoid development, microglia phenotypes, and neurodevelopmental timing anomalies in autism. His team’s work also explores zika virus interactions with glioblastoma stem cells and neuronal plasticity in psychiatric disorders. Scientific awards and funding include support from the Deutsche Forschungsgemeinschaft (DFG), Brain & Behavior Research Foundation (BBRF), and Munich Cluster for Systems Neurology (SyNergy). Collaborations span institutions like the TUM Center for Organoid Systems. Advises 6 students (2 PhD, 1 MSc, 3 associated) Labs include Schäfer Lab, COS@TranslaTUM Contact: simon.schafer@tum.de
Prof. Dr. Niels Pinkwart is a Professor of Computer Science at Humboldt University Berlin and Scientific Director of the Educational Technology Lab at the DFKI Berlin Project Office. His work focuses on AI-driven educational technologies, including roles as spokesperson for the interdisciplinary ProMINT program and leadership positions in the German Society for Informatics' Learning Analytics and Educational Technologies working groups. Education: Computer Science and Mathematics at University of Duisburg Doctorate: Collaborative learning technologies (2005) Postdoctoral: Carnegie Mellon University's Human-Computer Interaction Institute Research interests span educational technologies , human-AI collaboration , and digital learning systems , with applications in serious games for ASD , creativity assessment , and healthcare informatics . His publications (over 200) demonstrate expertise in scaling educational mentoring through AI. Current affiliations include the Einstein Center Digital Future and Weizenbaum Institute for the Networked Society. He has led projects like AZUKIT (AI tutors for performance assessment), tech4comp (scalable mentoring processes), and AI.EDU Lab (AI in higher education).
Prof. Dr. Amelie Hagelauer holds a professorship in Micro- and Nanosystem Technology at the TUM School of Computation, Information and Technology, Technical University of Munich. Her work focuses on advanced electronics and systems integration across quantum computing hardware, resistive memory technologies, and high-frequency RF systems. She has contributed to innovations in superconducting qubit readout architectures, multi-level RRAM designs, and 3D-integrated CMOS-compatible quantum devices. Research interests span quantum hardware design, nanoelectronic devices, RF front-end systems, and emerging memory technologies. Her work emphasizes practical implementation challenges such as low-power operation, high-voltage handling in RF switches, and wafer-scale fabrication processes. Recent projects include D-band radar systems, energy-efficient 60 GHz transceivers, and antenna tuning solutions for 5G applications. Publications from 2023-2025 showcase advancements in resistive switching device characterization, mitigation of TLS losses in superconducting qubits, and reconfigurable AI accelerators using RRAM-based digital twins. Her work bridges theoretical device physics with practical integrated circuit design, addressing scalability and reliability in next-gen electronics. Awards and grants: None explicitly listed in provided texts. Active collaborations include EU-funded projects on quantum computing platforms and TUM's Electronic Photonic Integration initiatives. Leads research teams in microsystem technology with emphasis on cross-disciplinary approaches combining CMOS processes, MEMS, and quantum engineering.
Prof. Dr. Patrick Huber is a leading physicist and Institute Director at the Hamburg University of Technology (TUHH) , heading the Institute for Materials and X-Ray Physics (M-2) . He also leads the High-Resolution X-Ray Analytics of Materials group at DESY through a cooperative professorship. His research spans condensed matter physics , nanoporous materials , and X-ray analytics , with significant contributions to molecular water science and soft matter in confinement . Education: PhD in Physics (1999, Saarland University), Diploma in Physics (1995, Saarland University) Professional Career: Full Professor at TUHH (2020-present), Member of CRC 1615 (2023-present), Spokesperson for CMWS (2024-present), Cluster of Excellence BlueMat (2025) Research Interests focus on multi-scale material behavior under extreme confinement, particularly hierarchical porous silicon and silica systems . His work examines adsorption-induced deformation , elastocapillarity , fluid transport in nanopores, and metamaterial design principles using electrolytes , polymers , and liquid crystals . Fundamental studies include fluid interface thermodynamics and microscopic hydrodynamics . Scientific Awards include the Top Reviewer Award (2018) from Applied Physics Letters and the Dr.-Eduard-Martin Award (2000) for his dissertation. He contributes to 130+ publications with an h-index of 36 (2021). Advising and Grants involve supervising 18 doctoral and master's students , including Manuel Brinker , Marc Thelen , and Stella Gries . He participates in Collaborative Research Centre CRC 1615 , Cluster of Excellence EXC 3120 BlueMat , and the United Nations University Hub on Climate Engineering . Laboratory and Teams include the Institute for Materials and X-Ray Physics (M-2) at TUHH, the High-Resolution X-Ray Analytics group at DESY, and contributions to the Centre for Hybrid Nanostructures (CHyN) .
Thomas Grote is a Research Fellow at the University of Tübingen's Ethics and Philosophy Lab within the Cluster of Excellence 'Machine Learning: New Perspectives for Science'. His research focuses on philosophical and ethical dimensions of artificial intelligence, particularly interpretability, fairness, and reliability in medical and social contexts. He co-supervises the Carl-Zeiss-Stiftung-funded project 'Certification and Foundations of Safe Machine Learning Systems in Healthcare' and co-organizes the 'Philosophy of Science Meets Machine Learning' conference series. Research Focus Grote's interdisciplinary work bridges philosophy of science and applied AI ethics. Key areas include: Methodological foundations of AI ethics and epistemology Clinical reliability and safety of ML systems Fairness metrics in sociotechnical healthcare systems Interpretability requirements for medical AI Computational psychiatry and evolving mental health frameworks His recent publications demonstrate strong emphasis on healthcare applications, with critical analyses of reliability in foundation models, ethical paradigms for LLMs, and rethinking evaluation methodologies at the epistemology-ethics interface.
